ENvue Medical, Inc.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Doron Robert Besser
- Full Time Employees
- 13
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Address
- 969 Pruitt Ave Tyler TX United States of America 77569
- IPO Date
- Dec 12, 2025
- CIK
- 0001326706
- Website
- envuemed.com
- Similar Companies
- Business
- ENvue Medical, Inc. is a medical technology company focused on non-invasive and minimally invasive enteral care solutions and navigation systems for clinical and home settings. The company develops intelligent enteral care platforms that integrate feeding-tube placement navigation with related equipment and supplies, alongside acoustic-based therapeutic technologies for pain management and biofilm disruption, to improve patient safety and comfort during enteral therapy. ENvue Medical is headquartered in Tyler, Texas, United States, and maintains R&D operations in Tel Aviv and Nesher, Israel, with a broadened U.S. hospital footprint and expanding international activity through partnerships and product developments. Founded in 2019, the company positions its offerings across critical care, ICU, general hospital, and home-care segments, emphasizing safe feeding-tube placement, enteral delivery tools, patient comfort with indwelling tubes, and acoustic-based therapies. Core products and services include the ENvue Navigation Platform for electromagnetic-guided feeding-tube placement; compatible ENvue-branded feeding tubes and accessories; acoustic-based therapeutic devices such as PainShield and UroShield for non-opioid pain management and infection control; over-the-counter ENFit syringes and related consumables; and ongoing research initiatives to extend platform capabilities into pediatric and vascular access applications. Latest major company changes include strategic partnerships and alliances to extend clinical adoption and distribution, expansion of hospital networks in the United States (notably a multi-site rollout reaching dozens of facilities), and ongoing product line enhancements and platform integrations leveraging NanoVibronix technologies for enteral care and pain management. The company also announces continual platform evolution, regulatory considerations, and potential future expansions related to pediatric care and broader vascular access applications as part of its growth strategy. ENvue Medical operates within the broader NanoVibronix corporate family, incorporating its Acoustic-based therapeutic technologies alongside its ENvue navigation offerings to deliver integrated solutions for patient safety, clinical usability, and care continuity.
Company News
ENvue Medical Provides Nasdaq Listing Update
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
Envue Medical Expands AI Navigation Platform With Robotic Prototype
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
Brazil Potash Awards Front End Engineering Design (FEED) Contract For Mine Shafts and Underground Development to WSP UK Ltd., with Redpath Deilmann Mining Inc. as Subconsultants, Completing Full-Project FEED Coverage at Autazes
Ohmium and Hynfra Sign Master Cooperation Agreement to Advance Large-Scale Green Hydrogen Projects in the Middle East and Africa
ENvue Medical Launches AI Training Platform Establishing Artificial Intelligence Foundation for Robotic Feeding Tube Navigation
ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
ENvue Medical Announces Publication of Landmark Independent Study Highlighting Significant Safety, Time-, and Cost-Saving Benefits of ENvue Navigation Platform in Multi-Hospital System
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
ENvue Medical Secures Three-Year Contract Renewal at 12-Hospital U.S. Health Network as the ENvue™ Navigation Platform Becomes Standard of Care
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
Brazil Potash Awards Front-End Engineering Design (FEED) Contract for Surface Facilities and Infrastructure to Wood and Promon Engenharia, Advancing Bankability of the Autazes Project